Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with

  • PDF / 944,369 Bytes
  • 11 Pages / 595.276 x 790.866 pts Page_size
  • 63 Downloads / 227 Views

DOWNLOAD

REPORT


ORIGINAL ARTICLE

Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumab Nalee Kim1 · Jeong Il Yu1   · Hee Chul Park1,2 · Gyu Sang Yoo1 · Changhoon Choi1 · Jung Yong Hong3 · Ho Yeong Lim3 · Jeeyun Lee3 · Moon Seok Choi3 · Jung Eun Lee3 · Kyunga Kim4 Received: 28 July 2020 / Accepted: 7 November 2020 © Springer-Verlag GmbH Germany, part of Springer Nature 2020

Abstract Background  We investigated the combined effects of sarcopenia and inflammation on outcomes in patients with HCC treated with nivolumab. Materials and Methods  We reviewed 102 patients treated with nivolumab between 2017 and 2018. Sarcopenia was diagnosed when the L3 skeletal muscle indices were